Bellipharma
ActiveSummary
Bellipharma has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €214,395 and a net result of -€9,471. Equity is growing by about 4.1% per year across the filed financial years. Its solvency ranks better than 47% of 22,027 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
22-01
Gazette deed
Appointment: Crown Consultancy bv (director)Permanent representative: Him OMAR · Power of attorney · Amendment of the articles11 facts ▸
- Director appointment, Crown Consultancy bv (director (not named in the articles))
- Permanent representative, Him OMAR
- Other provision, “Volmacht voor de coördinatie, ZEVENDE BESLISSING” (deed in Dutch)
- Power of attorney
- General meeting, 09-12-2025
- Amendment of the articles (2 times)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Capital conversion, “beschikbaar voor uitkering” (deed in Dutch)
- Name change, Bellipharma
- Registered-office move, 1030 Brussel,Simon Bolivarlaan 21-23
- Capital contribution
Show earlier events
About the unread acts
Of the 8 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 7 have not been read yet: what they contain is neither established nor disproved here.